Your browser doesn't support javascript.
loading
Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series
Sky Vanderburg; Narges Alipanah; Rebecca Crowder; Christina Yoon; Richard Wang; Neeta Thakur; Kristin Slown; Priya B Shete; Martin Rofael; John Z Metcalfe; Cindy Merrifield; Carina Marquez; Katherine Malcolm; Michael Lipnick; Vivek Jain; Antonio Gomez; Gregory Burns; Lillian B Brown; Christopher Berger; Vincent Auyeung; Adithya Cattamanchi; Carolyn M Hendrickson.
Afiliação
  • Sky Vanderburg; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • Narges Alipanah; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • Rebecca Crowder; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Christina Yoon; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Richard Wang; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Neeta Thakur; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Kristin Slown; 3. Department of Pharmaceutical Services, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Priya B Shete; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Martin Rofael; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • John Z Metcalfe; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Cindy Merrifield; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Carina Marquez; 4. Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Fr
  • Katherine Malcolm; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • Michael Lipnick; 5. Department of Anesthesia and Perioperative Care, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Vivek Jain; 4. Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Fr
  • Antonio Gomez; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Gregory Burns; 5. Department of Anesthesia and Perioperative Care, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Lillian B Brown; 4. Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Fr
  • Christopher Berger; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • Vincent Auyeung; 1. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco CA, USA
  • Adithya Cattamanchi; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
  • Carolyn M Hendrickson; 2. Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20114090
ABSTRACT
BackgroundFollowing early implementation of public health measures, San Francisco has experienced a slow rise and a low peak level of coronavirus disease 2019 (COVID-19) cases and deaths. Methods and FindingsWe included all patients with COVID-19 pneumonia admitted to the intensive care unit (ICU) at the safety net hospital for San Francisco through April 8, 2020. Each patient had [≥]15 days of follow-up. Among 26 patients, the median age was 54 years (interquartile range, 43 to 62), 65% were men, and 77% were Latinx. Mechanical ventilation was initiated for 11 (42%) patients within 24 hours of ICU admission and 20 patients (77%) overall. The median duration of mechanical ventilation was 13.5 days (interquartile range, 5 to 20). Patients were managed with lung protective ventilation (tidal volume [≤]8 ml/kg of ideal body weight and plateau pressure [≤]30 cmH2O on 98% and 78% of ventilator days, respectively). Prone positioning was used for 13 of 20 (65%) ventilated patients for a median of 5 days (interquartile range, 2 to 10). Seventeen (65%) patients were discharged home, 1 (4%) was discharged to nursing home, 3 (12%) were discharged from the ICU, and 2 (8%) remain intubated in the ICU at the time of this report. Three (12%) patients have died. ConclusionsGood outcomes were achieved in critically ill patients with COVID-19 by using standard therapies for acute respiratory distress syndrome (ARDS) such as lung protective ventilation and prone positioning. Ensuring hospitals can deliver sustained high-quality and evidence-based critical care to patients with ARDS should remain a priority.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...